Neuroprotective Effects of the Glutamate Transporter Activator (R)-(−)-5-methyl-1-nicotinoyl-2-pyrazoline (MS-153) following Traumatic Brain Injury in the Adult Rat

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Journal of Neurotrauma

• Publication date

  2016-05-24

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1089/neu.2015.4079PMID 26200170PMCID PMC4892232
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Effects of (R)‐(−)‐5‐methyl‐1‐nicotinoyl‐2‐pyrazoline on glutamate transporter 1 and cysteine/glutamate exchanger as well as ethanol drinking behavior in male, alcohol‐preferring rats

  2015cited by this paper
• Effects of MS-153 on chronic ethanol consumption and GLT1 modulation of glutamate levels in male alcohol-preferring rats

  2014cited by this paper
• Neuroprotectants Targeting NMDA Receptor Signaling

  2014cited by this paper
• Upregulation of GLT‐1 by treatment with ceftriaxone alleviates radicular pain by reducing spinal astrocyte activation and neuronal hyperexcitability

  2014cited by this paper
• Neuroprotective effect of ceftriaxone in a rat model of traumatic brain injury

  2014cited by this paper
• Riluzole Partially Rescues Age-Associated, but not LPS-Induced, Loss of Glutamate Transporters and Spatial Memory

  2013cited by this paper
• Ceftriaxone Treatment after Traumatic Brain Injury Restores Expression of the Glutamate Transporter, GLT-1, Reduces Regional Gliosis, and Reduces Post-Traumatic Seizures in the Rat

  2013cited by this paper
• Design and Initial Results of a Multi-Phase Randomized Trial of Ceftriaxone in Amyotrophic Lateral Sclerosis

  2013cited by this paper
• The beta-lactam antibiotic, ceftriaxone, provides neuroprotective potential via anti-excitotoxicity and anti-inflammation response in a rat model of traumatic brain injury

  2012cited by this paper
• Antinociceptive evaluation of ceftriaxone and minocycline alone and in combination in a neuropathic pain model in rat.

  2012cited by this paper
• Role of Excitatory Amino Acid Transporter‐2 (EAAT2) and glutamate in neurodegeneration: Opportunities for developing novel therapeutics

  2011influential reference
• [Effects of β-lactam antibiotics ceftriaxone on expression of glutamate in hippocampus after traumatic brain injury in rats].

  2011cited by this paper
• Concussive Brain Trauma in the Mouse Results in Acute Cognitive Deficits and Sustained Impairment of Axonal Function

  2011cited by this paper
• Animal modelling of traumatic brain injury in preclinical drug development: where do we go from here?

  2011cited by this paper
• Harmine, a natural beta-carboline alkaloid, upregulates astroglial glutamate transporter expression.

  2011cited by this paper
• β-Lactam antibiotic produces a sustained reduction in extracellular glutamate in the nucleus accumbens of rats

  2011cited by this paper
• Exploring New Routes for Neuroprotective Drug Development in Traumatic Brain Injury

  2010influential reference
• Dopamine receptor expression and distribution dynamically change in the rat nucleus accumbens after withdrawal from cocaine self-administration.

  2010cited by this paper
• Spinal upregulation of glutamate transporter GLT-1 by ceftriaxone: therapeutic efficacy in a range of experimental nervous system disorders.

  2010cited by this paper
• Glutamate receptors, neurotoxicity and neurodegeneration

  2010cited by this paper
• Nimodipine can improve cerebral metabolism and outcome in patients with severe head trauma.

  2009cited by this paper
• Na+,K+-ATPase activity impairment after experimental traumatic brain injury: relationship to spatial learning deficits and oxidative stress.

  2008cited by this paper
• Involvement of microtubule-associated protein 2 (MAP2) in oral cancer cell motility: a novel biological function of MAP2 in non-neuronal cells.

  2008cited by this paper
• Midline brain injury in the immature rat induces sustained cognitive deficits, bihemispheric axonal injury and neurodegeneration.

  2008cited by this paper
• Glutamate forward and reverse transport: From molecular mechanism to transporter‐mediated release after ischemia

  2008cited by this paper
• PKC‐dependent endocytosis of the GLT1 glutamate transporter depends on ubiquitylation of lysines located in a C‐terminal cluster

  2008cited by this paper
• EAAT2 regulation and splicing: relevance to psychiatric and neurological disorders

  2007cited by this paper
• The role of glutamate transporters in neurodegenerative diseases and potential opportunities for intervention.

  2007influential reference
• Pathophysiology of traumatic brain injury.

  2007cited by this paper
• Enhancing Glutamate Transport: Mechanism of Action of Parawixin1, a Neuroprotective Compound from Parawixia bistriata Spider Venom

  2007cited by this paper
• Excitotoxic mechanisms and the role of astrocytic glutamate transporters in traumatic brain injury.

  2006cited by this paper
• Differential Behavioral and Histopathological Responses to Graded Cortical Impact Injury in Mice

  2006cited by this paper
• Glutamate-based therapeutic approaches: targeting the glutamate transport system.

  2006cited by this paper
• Decreased Expression of Glutamate Transporters in Astrocytes after Human Traumatic Brain Injury

  2006cited by this paper
• β-Lactam antibiotics offer neuroprotection by increasing glutamate transporter expression

  2005cited by this paper
• Faculty Opinions recommendation of Beta-lactam antibiotics offer neuroprotection by increasing glutamate transporter expression.

  2005cited by this paper
• Effect of MS-153, a glutamate transporter activator, on the conditioned rewarding effects of morphine, methamphetamine and cocaine in mice.

  2005cited by this paper
• Guanosine Enhances Glutamate Transport Capacity in Brain Cortical Slices

  2005cited by this paper
• Nicergoline enhances glutamate uptake via glutamate transporters in rat cortical synaptosomes.

  2004cited by this paper
• Effect of MS-153 on the acquisition and expression of conditioned fear in rats.

  2004cited by this paper
• Altered expression of the glutamate transporter EAAT2b in neurological disease

  2004cited by this paper
• Cell Death Mechanisms Following Traumatic Brain Injury

  2004cited by this paper
• Purification of a neuroprotective component of Parawixia bistriata spider venom that enhances glutamate uptake

  2003cited by this paper
• The ‘glial’ glutamate transporter, EAAT2 (Glt‐1) accounts for high affinity glutamate uptake into adult rodent nerve endings

  2003cited by this paper
• Why did NMDA receptor antagonists fail clinical trials for stroke and traumatic brain injury?

  2002cited by this paper
• Excitatory amino acid transporters: keeping up with glutamate.

  2002cited by this paper
• Effect of MS-153 on the development of behavioral sensitization to locomotion- and ataxia-inducing effects of phencyclidine

  2002cited by this paper
• The expression of excitatory amino acid transporter 2 in traumatic brain injury.

  2002cited by this paper
• Effect of MS-153 on the development of behavioral sensitization to stereotypy-inducing effect of phencyclidine.

  2002cited by this paper
• Inhibition of morphine tolerance and dependence by MS-153, a glutamate transporter activator.

  2001cited by this paper
• Activation of glutamate uptake by guanosine in primary astrocyte cultures

  2001cited by this paper
• Glutamate uptake.

  2001influential reference
• Neuronal injury and loss after traumatic brain injury: time course and regional variability.

  2001cited by this paper
• Antisense knockdown of the glial glutamate transporter GLT-1 exacerbates hippocampal neuronal damage following traumatic injury to rat brain.

  2001cited by this paper
• Acute decrease in net glutamate uptake during energy deprivation.

  2000cited by this paper
• The high-affinity glutamate transporters GLT1, GLAST, and EAAT4 are regulated via different signalling mechanisms.

  2000cited by this paper
• Assessment of Agents for the Treatment of Head Injury

  2000cited by this paper
• Riluzole increases high-affinity glutamate uptake in rat spinal cord synaptosomes.

  2000cited by this paper
• The Novel Compound LOE 908 Attenuates Acute Neuromotor Dysfunction but Not Cognitive Impairment or Cortical Tissue Loss Following Traumatic Brain Injury in Rats

  2000cited by this paper
• Riluzole and Methylprednisolone Combined Treatment Improves Functional Recovery in Traumatic Spinal Cord Injury

  2000cited by this paper
• CSF and ECF glutamate concentrations in head injured patients.

  1999cited by this paper
• Ion Channel Modulation as the Basis for Neuroprotective Action of MS‐153

  1999cited by this paper
• The neuroprotective agent MS-153 stimulates glutamate uptake.

  1999cited by this paper
• Increase in extracellular glutamate caused by reduced cerebral perfusion pressure and seizures after human traumatic brain injury: a microdialysis study.

  1998cited by this paper
• The Neuronal Cytoskeleton Is at Risk After Mild and Moderate Brain Injury

  1998cited by this paper
• Traumatic Brain Injury Down‐Regulates Glial Glutamate Transporter (GLT‐1 and GLAST) Proteins in Rat Brain

  1998cited by this paper
• Glutamate receptor antagonists inhibit calpain-mediated cytoskeletal proteolysis in focal cerebral ischemia.

  1998cited by this paper
• Clinical Significance of CSF Glutamate Concentrations Following Severe Traumatic Brain Injury in Humans

  1998cited by this paper
• Riluzole attenuates cortical lesion size, but not hippocampal neuronal loss, following traumatic brain injury in the rat

  1998cited by this paper
• Ca(2+)-dependent mechanisms of cell injury in cultured cortical neurons.

  1998cited by this paper
• Cerebroprotective effects of a novel pyrazoline derivative, MS-153, on focal ischemia in rats.

  1997cited by this paper
• Modulation of non-vesicular glutamate release by pH

  1996cited by this paper
• Mechanisms of glutamate and aspartate release in the ischemic rat cerebral cortex.

  1996cited by this paper
• Riluzole, a Novel Neuroprotective Agent, Attenuates Both Neurologic Motor and Cognitive Dysfunction Following Experimental Brain Injury in the Rat

  1996cited by this paper
• Prolonged Calpain‐mediated Spectrin Breakdown Occurs Regionally Following Experimental Brain Injury in the Rat

  1996cited by this paper
• Inhibitory effect of MS-153 on elevated brain glutamate level induced by rat middle cerebral artery occlusion.

  1996cited by this paper
• Excitotoxicity and the NMDA receptor--still lethal after eight years.

  1995cited by this paper
• Temporal response and effects of excitatory amino acid antagonism on microtubule-associated protein 2 immunoreactivity following experimental brain injury in rats.

  1995cited by this paper
• Triggering and execution of neuronal death in brain ischaemia: two phases of glutamate release by different mechanisms.

  1994cited by this paper
• Alterations of Protein Kinase C in Rat Hippocampus Following Traumatic Brain Injury

  1993cited by this paper
• Excitatory amino acids in cerebrospinal fluid following traumatic brain injury in humans.

  1993cited by this paper
• Traumatic Brain Injury‐Induced Excitotoxicity Assessed in a Controlled Cortical Impact Model

  1993influential reference
• Cloning and expression of a rat brain L-glutamate transporter

  1992cited by this paper
• Evaluation of a novel calcium channel blocker, (S)-emopamil, on regional cerebral edema and neurobehavioral function after experimental brain injury.

  1992cited by this paper
• Changes in Cortical Extracellular Levels of Energy-Related Metabolites and Amino Acids following Concussive Brain Injury in Rats

  1990cited by this paper
• Non-vesicular release of glutamate from glial cells by reversed electrogenic glutamate uptake

  1990cited by this paper
• Massive increases in extracellular potassium and the indiscriminate release of glutamate following concussive brain injury.

  1990cited by this paper
• The role of excitatory amino acids and NMDA receptors in traumatic brain injury.

  1989cited by this paper
• Traumatic brain injury in the rat: characterization of a lateral fluid-percussion model.

  1989cited by this paper

• Neuroprotective role of GLT-1/EAAT2 in glutamate-induced excitotoxicity.

  2025cites this paper
• The link between impact-induced tensile strain and dendritic spine morphology in porcine brain tissue

  2025cites this paper
• Bone marrow stromal cells-derived exosomes reduce neurological damage in traumatic brain injury through the miR-124-3p/p38 MAPK/GLT-1 axis.

  2023cites this paper
• A Medicinal Chemistry Perspective on Excitatory Amino Acid Transporter 2 Dysfunction in Neurodegenerative Diseases

  2023cites this paper
• GLUTAMATE AS A TARGET THERAPY FOR ALCOHOL DEPENDENCE DISORDER

  2023cites this paper
• Neuropharmacological insight into preventive intervention in posttraumatic epilepsy based on regulating glutamate homeostasis

  2023cites this paper
• Exosomes derived from bone marrow mesenchymal stem cells attenuate neurological damage in traumatic brain injury by alleviating glutamate-mediated excitotoxicity.

  2022cites this paper
• Glutamatergic Systems in Neuropathic Pain and Emerging Non-opioid Therapies.

  2022cites this paper
• Reaction of 7α-bromo-6-nitrocholest-5-enes with hydrazine: Formation of steroidal pyrazolines and molecular docking against SARS-CoV-2 omicron protease

  2022cites this paper
• Reactive astrocytes: The nexus of pathological and clinical hallmarks of Alzheimer’s disease

  2021cites this paper
• Rapid Regulation of Glutamate Transport: Where Do We Go from Here?

  2021cites this paper
• Revisiting Traumatic Brain Injury: From Molecular Mechanisms to Therapeutic Interventions

  2020cites this paper
• Transplantation of mesenchymal stem cells overexpressing interleukin‐10 induces autophagy response and promotes neuroprotection in a rat model of TBI

  2019cites this paper
• Synthesis, molecular docking, and biological evaluation of novel 2-pyrazoline derivatives as multifunctional agents for the treatment of Alzheimer's disease.

  2019cites this paper
• Assessment of neuropharmacological potential of low molecular weight components extracted from Rhinella schneideri toad poison

  2019cites this paper
• Membrane transporters in traumatic brain injury: Pathological, pharmacotherapeutic, and developmental implications.

  2019cites this paper
• Incretin Mimetics as Rational Candidates for the Treatment of Traumatic Brain Injury.

  2019cites this paper
• Development and Validation of a HPLC Method for MS-153 Quantification: Assessment of its Stability in Rat Plasma and Brain Homogenate

  2018cites this paper
• Synthesis and biological evaluation of novel pyrazoline-based aromatic sulfamates with potent carbonic anhydrase isoforms II, IV and IX inhibitory efficacy.

  2018cites this paper
• Glutamate Dehydrogenase as a Neuroprotective Target Against Neurodegeneration

  2018cites this paper
• Differential Response of Neural Cells to Trauma-Induced Swelling In Vitro

  2018cites this paper
• Development of a systems‐based in situ multiplex biomarker screening approach for the assessment of immunopathology and neural tissue plasticity in male rats after traumatic brain injury

  2018cites this paper
• Mechanisms of Endogenous Neuroprotective Effects of Astrocytes in Brain Injury

  2018cites this paper
• Ca2+, Astrocyte Activation and Calcineurin/NFAT Signaling in Age-Related Neurodegenerative Diseases

  2018cites this paper
• Protocols for Measuring Glutamate Uptake: Dose‐Response and Kinetic Assays in In Vitro and Ex Vivo Systems

  2018cites this paper
• Drugs to Alter Extracellular Concentration of Glutamate: Modulators of Glutamate Uptake Systems

  2018cites this paper
• Biochemical Approaches for Glutamatergic Neurotransmission

  2018cites this paper
• Calcineurin/NFAT Signaling in Activated Astrocytes Drives Network Hyperexcitability in Aβ-Bearing Mice

  2017influential citation
• Glutamate dehydrogenase as a neuroprotective target against brain ischemia and reperfusion.

  2017cites this paper
• Protection of FK506 against neuronal apoptosis and axonal injury following experimental diffuse axonal injury

  2017influential citation
• Protective Effects of Calpain Inhibition on Neurovascular Unit Injury through Downregulating Nuclear Factor-κB-related Inflammation during Traumatic Brain Injury in Mice

  2017cites this paper
• Excess cerebral TNF causing glutamate excitotoxicity rationalizes treatment of neurodegenerative diseases and neurogenic pain by anti-TNF agents

  2016cites this paper
• Activity dependent internalization of the glutamate transporter GLT-1 mediated by β-arrestin 1 and ubiquitination.

  2016cites this paper
• GLT-1-Dependent Disruption of CNS Glutamate Homeostasis and Neuronal Function by the Protozoan Parasite Toxoplasma gondii

  2016cites this paper
• Chronic Glutamate Toxicity in Neurodegenerative Diseases—What is the Evidence?

  2015cites this paper
• Current approaches to enhance glutamate transporter function and expression

  2015cites this paper